859
Views
33
CrossRef citations to date
0
Altmetric
Rheumatoid Arthritis

Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalence estimates using a nationwide population-based questionnaire survey

, , , , , , & show all
Pages 941-947 | Received 29 Aug 2019, Accepted 15 Oct 2019, Published online: 14 Nov 2019
 

Abstract

Objectives: To elucidate the epidemiological characteristics of patients with rheumatoid arthritis (RA) in Japan using data from the Comprehensive Survey of Living Conditions, a nationwide questionnaire survey conducted in 2016.

Methods: In total, 222,365 men and 245,251 women aged ≥16 years were included in the study. RA patients were defined as those who reported ‘currently receiving treatment for RA at hospitals, clinics, or a facility for Japanese traditional massage, acupuncture, moxibustion, or judo-orthopedics.’ The number of RA patients was estimated from the age-specific prevalence and total Japanese population in 2016. Further, the prevalence of individuals experiencing difficulties in activities of daily living due to health problems and those with mental distress as evaluated by K6 Scale was examined.

Results: The estimated number and prevalence of RA in Japan with 95% confidence interval was 822 (768–880) thousand and 0.75% (0.70–0.80%). The population peaked in the late 60s, and the prevalence continued increasing until the early 80s, regardless of sex. Compared with non-RA participants, RA patients were more likely to experience difficulties in activities and to be distressed.

Conclusion: High prevalence of RA in older age and mental and physical burden among RA patients were confirmed.

Acknowledgements

The authors thank Prof. Yoshitaka Murakami, Department of Medical Statistics, Toho University for the statistical advice.

Conflict of interest

None.

Additional information

Funding

This study was supported by JSPS KAKENHI Grant Number JP 26460608.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.